As legislation that would force drug companies to stop using Chinese development and manufacturing contractors goes to a markup in the US House next week, the Biotechnology Innovation Organization has released an industry survey that found decoupling could be significantly disruptive.
BIO is hoping the results will help persuade lawmakers to provide a “substantial runway to begin and implement the decoupling...





